SeaStar Medical Holding Corporation Logo

SeaStar Medical Holding Corporation

ICU

(1.8)
Stock Price

7,30 USD

-1583.09% ROA

306.19% ROE

-0.29x PER

Market Cap.

21.566.618,00 USD

-63.68% DER

0% Yield

0% NPM

SeaStar Medical Holding Corporation Stock Analysis

SeaStar Medical Holding Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

SeaStar Medical Holding Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (54.53%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

The stock's low PBV ratio (-0.55x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (-107%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

5 ROA

The stock's ROA (-482.76%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

SeaStar Medical Holding Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

SeaStar Medical Holding Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

SeaStar Medical Holding Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

SeaStar Medical Holding Corporation Revenue
Year Revenue Growth
2020 0
2021 0 0%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

SeaStar Medical Holding Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2020 4.025.000
2021 2.766.000 -45.52%
2022 2.819.000 1.88%
2023 4.428.000 36.34%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

SeaStar Medical Holding Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2020 2.428.000
2021 1.683.000 -44.27%
2022 6.600.000 74.5%
2023 7.316.000 9.79%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

SeaStar Medical Holding Corporation EBITDA
Year EBITDA Growth
2020 -6.369.000
2021 -4.358.000 -46.15%
2022 -11.609.000 62.46%
2023 -11.148.000 -4.14%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

SeaStar Medical Holding Corporation Gross Profit
Year Gross Profit Growth
2020 0
2021 0 0%
2022 0 0%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

SeaStar Medical Holding Corporation Net Profit
Year Net Profit Growth
2020 -3.276.000
2021 -4.596.000 28.72%
2022 -23.013.000 80.03%
2023 -29.704.000 22.53%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

SeaStar Medical Holding Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2020 0
2021 -1 0%
2022 -3 100%
2023 -1 -100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

SeaStar Medical Holding Corporation Free Cashflow
Year Free Cashflow Growth
2020 -5.572.000
2021 -5.114.000 -8.96%
2022 -7.794.000 34.39%
2023 -1.337.000 -482.95%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

SeaStar Medical Holding Corporation Operating Cashflow
Year Operating Cashflow Growth
2020 -5.572.000
2021 -5.114.000 -8.96%
2022 -7.794.000 34.39%
2023 -1.337.000 -482.95%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

SeaStar Medical Holding Corporation Capital Expenditure
Year Capital Expenditure Growth
2020 0
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

SeaStar Medical Holding Corporation Equity
Year Equity Growth
2020 -71.583.000
2021 -76.165.000 6.02%
2022 -8.235.000 -824.89%
2023 -15.903.000 48.22%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

SeaStar Medical Holding Corporation Assets
Year Assets Growth
2020 2.909.000
2021 603.000 -382.42%
2022 4.767.000 87.35%
2023 2.247.000 -112.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

SeaStar Medical Holding Corporation Liabilities
Year Liabilities Growth
2020 74.492.000
2021 76.768.000 2.96%
2022 13.002.000 -490.43%
2023 18.150.000 28.36%

SeaStar Medical Holding Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-1.77
Price to Earning Ratio
-0.29x
Price To Sales Ratio
0x
POCF Ratio
-0.92
PFCF Ratio
-1.94
Price to Book Ratio
-0.65
EV to Sales
0
EV Over EBITDA
-1.68
EV to Operating CashFlow
-2.85
EV to FreeCashFlow
-2.85
Earnings Yield
-3.47
FreeCashFlow Yield
-0.51
Market Cap
0,02 Bil.
Enterprise Value
0,03 Bil.
Graham Number
5.63
Graham NetNet
-0.9

Income Statement Metrics

Net Income per Share
-1.77
Income Quality
0.31
ROE
3.06
Return On Assets
-15.83
Return On Capital Employed
1.86
Net Income per EBT
1
EBT Per Ebit
1.87
Ebit per Revenue
0
Effective Tax Rate
-0.02

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.55
Free CashFlow per Share
-0.55
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
3.32
Return on Tangible Assets
-15.83
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,79
Tangible Book Value per Share
-0.79
Shareholders Equity per Share
-0.79
Interest Debt per Share
0.56
Debt to Equity
-0.64
Debt to Assets
4.51
Net Debt to EBITDA
-0.53
Current Ratio
0.18
Tangible Asset Value
-0,02 Bil.
Net Current Asset Value
-0,02 Bil.
Invested Capital
-0.64
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.47

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

SeaStar Medical Holding Corporation Dividends
Year Dividends Growth

SeaStar Medical Holding Corporation Profile

About SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.

CEO
Mr. Eric Schlorff
Employee
9
Address
3513 Brighton Boulevard
Denver, 80216

SeaStar Medical Holding Corporation Executives & BODs

SeaStar Medical Holding Corporation Executives & BODs
# Name Age
1 Dr. H. David Humes M.D.
Co-Founder and Managing Director
70
2 Tom Mullen
Vice President of Operations & Product Development
70
3 Mr. Eric Schlorff
Chief Executive Officer, President & Executive Director
70
4 Mr. David A. Green CPA, M.B.A.
Chief Financial Officer
70
5 Colonel Kevin Chung FACP, M.D.
Chief Medical Officer
70

SeaStar Medical Holding Corporation Competitors